This has grown by acquisition, buying a lot of drugs. They sell drugs to over 100 companies. Generates EBITDA of around $600 million. Have $3.5 billion of debt. They free cash flow $300 million a year which they can pay down the debt with. Thinks there is a very good chance this company will not be public in a couple of weeks. Dividend yield of 1.14%.
Concordia Healthcare Corp is a American stock, trading under the symbol CXRX-Q on the NASDAQ (CXRX). It is usually referred to as NASDAQ:CXRX or CXRX-Q
In the last year, there was no coverage of Concordia Healthcare Corp published on Stockchase.
Concordia Healthcare Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for Concordia Healthcare Corp.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Concordia Healthcare Corp published on Stockchase.
On 2019-08-07, Concordia Healthcare Corp (CXRX-Q) stock closed at a price of $0.19.
(A Top Pick May 3/16. Down 95%.) This was a mistake. There are shareholder lawsuits involved. It was growth by acquisition, and it looks like they dramatically overpaid for some assets. They got involved with generic competition, and as well, the perfect storm of politics of the last election really killed the stock.